|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hormone/growth factor/membrane protein
|
 |
|
Title:
|
 |
Crystal structure analysis of the fgf10-fgfr2b complex
|
|
Structure:
|
 |
Fibroblast growth factor-10. Chain: a. Synonym: fgf-10, keratinocyte growth factor receptor, k- sam protein, protein tyrosine kinase, receptor like 14, fgf receptor, bacteria-expressed kinase, fibroblast growth factor receptor bek, tyrosylprotein kinase, hydroxyaryl- protein kinase. Engineered: yes. Fibroblast growth factor receptor 2 isoform 2.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: fgf10. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693.
|
|
Biol. unit:
|
 |
Tetramer (from
)
|
|
Resolution:
|
 |
|
2.90Å
|
R-factor:
|
0.239
|
R-free:
|
0.288
|
|
|
Authors:
|
 |
B.K.Yeh,M.Igarashi,A.V.Eliseenkova,A.N.Plotnikov,I.Sher, D.Ron,S.A.Aaronson,M.Mohammadi
|
Key ref:
|
 |
B.K.Yeh
et al.
(2003).
Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
Proc Natl Acad Sci U S A,
100,
2266-2271.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
31-Jan-03
|
Release date:
|
11-Feb-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain B:
E.C.2.7.10.1
- Receptor protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate
|
 |
 |
 |
 |
 |
ATP
|
+
|
[protein]-L-tyrosine
|
=
|
ADP
|
+
|
[protein]-L-tyrosine phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biochemical function
|
protein binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
100:2266-2271
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
|
|
B.K.Yeh,
M.Igarashi,
A.V.Eliseenkova,
A.N.Plotnikov,
I.Sher,
D.Ron,
S.A.Aaronson,
M.Mohammadi.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Binding specificity between fibroblast growth factors (FGFs) and their receptors
(FGFRs) is essential for mammalian development and is regulated primarily by two
alternatively spliced exons, IIIb ("b") and IIIc ("c"), that
encode the second half of Ig-like domain 3 (D3) of FGFRs. FGF7 and FGF10
activate only the b isoform of FGFR2 (FGFR2b). Here, we report the crystal
structure of the ligand-binding portion of FGFR2b bound to FGF10. Unique
contacts between divergent regions in FGF10 and two b-specific loops in D3
reveal the structural basis by which alternative splicing provides FGF10-FGFR2b
specificity. Structure-based mutagenesis of FGF10 confirms the importance of the
observed contacts for FGF10 biological activity. Interestingly, FGF10 binding
induces a previously unobserved rotation of receptor Ig domain 2 (D2) to
introduce specific contacts with FGF10. Hence, both D2 and D3 of FGFR2b
contribute to the exceptional specificity between FGF10 and FGFR2b. We propose
that ligand-induced conformational change in FGFRs may also play an important
role in determining specificity for other FGF-FGFR complexes.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 5.
Fig. 5. FGF10-induced D2 rotation contributes to
FGF10-FGFR2b specificity. (a) Relationship between the D2
domains after superimposition of FGF10 and FGF2 from the
FGF10-FGFR2b and FGF2-FGFR2c structures. For the sake of
clarity, D3 and the linker region are not shown. The direction
and degree of rotation between the two domains is shown. D2 of
FGFR2b is colored blue. D2 of FGFR2c is colored gray. The A' strands
of both domains are shown as -strand
arrows. The remainders of the domains are displayed as C coils.
FGF10 is shown in orange. (b) Interactions at the FGF10-D2
interface. The side chains of interacting residues are
displayed. (Right) A view of the FGF10-FGFR2b complex, with the
region of interest indicated by a square. FGF10 and FGFR2b are
colored as in Fig. 1. Oxygen atoms are colored red, nitrogen
blue, and carbon atoms the same color as the molecules to which
they belong.
|
 |
Figure 6.
Fig. 6. Conformation of the FGFR2b linker region. (a)
Interactions of the FGFR-invariant linker Arg-251 with FGF10.
The side chains of interacting residues are displayed. (Right) A
view of the whole FGF10-FGFR2b structure, with the region of
interest indicated by a square. FGF10 and FGFR2b are colored as
in Fig. 1. Oxygen atoms are colored red, nitrogen blue, and
carbon atoms the same color as the molecules to which they
belong. (b) Configuration of the FGFR-invariant linker Pro-253
in the FGF10-FGFR2b and FGF1-FGFR2c-heparin structures. The
equivalent D2s from the FGF10-FGFR2b and FGF1-FGFR2c-heparin
structures are superimposed (rmsd = 0.652 Å). FGFR2b is
colored yellow, and FGFR2c is colored blue. The location of the
linker prolines are indicated by arrows. Note the dramatic
difference in the position of D3 between the two structures. (c)
A FGF10-FGFR2b model with Pro-253 in the cis conformation. This
model was generated by separately superimposing FGF10 and
FGFR2b-D3 from the FGF10-FGFR2b structure onto FGF1 and
FGFR2c-D3 in the FGF1-FGFR2c-heparin structure (rmsd = 0.791
Å and 0.668 Å, respectively). D2 and D3 are shown in
green and blue, respectively. The alternatively spliced half of
D3 is colored purple. FGF1 is displayed as a black C coil, and
FGF10 is displayed as a thicker orange coil. FGF10 regions that
interact with D3 in the FGF10-FGFR2b structure are colored red.
In addition, FGF10 residues whose mutations reduce the ability
of FGF10 to activate FGFR2b are rendered in ball-and-stick. The
N and C termini of the receptor are labeled NT and CT,
respectively.
|
 |
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.Riazuddin,
Z.M.Ahmed,
R.S.Hegde,
S.N.Khan,
I.Nasir,
U.Shaukat,
S.Riazuddin,
J.A.Butman,
A.J.Griffith,
T.B.Friedman,
and
B.Y.Choi
(2011).
Variable expressivity of FGF3 mutations associated with deafness and LAMM syndrome.
|
| |
BMC Med Genet, 12,
21.
|
 |
|
|
|
|
 |
G.Ren,
J.Yin,
W.Wang,
L.Li,
and
D.Li
(2010).
Fibroblast growth factor (FGF)-21 signals through both FGF receptor-1 and 2.
|
| |
Sci China Life Sci, 53,
1000-1008.
|
 |
|
|
|
|
 |
S.Li,
E.Bock,
and
V.Berezin
(2010).
Neuritogenic and neuroprotective properties of Peptide agonists of the fibroblast growth factor receptor.
|
| |
Int J Mol Sci, 11,
2291-2305.
|
 |
|
|
|
|
 |
X.Wu,
Q.Yan,
Y.Huang,
H.Huang,
Z.Su,
J.Xiao,
Y.Zeng,
Y.Wang,
C.Nie,
Y.Yang,
and
X.Li
(2010).
Isolation of a novel basic FGF-binding peptide with potent antiangiogenetic activity.
|
| |
J Cell Mol Med, 14,
351-356.
|
 |
|
|
|
|
 |
B.C.Melnik,
G.Schmitz,
and
C.C.Zouboulis
(2009).
Anti-acne agents attenuate FGFR2 signal transduction in acne.
|
| |
J Invest Dermatol, 129,
1868-1877.
|
 |
|
|
|
|
 |
B.C.Melnik
(2009).
Role of FGFR2-signaling in the pathogenesis of acne.
|
| |
Dermatoendocrinol, 1,
141-156.
|
 |
|
|
|
|
 |
H.P.Makarenkova,
M.P.Hoffman,
A.Beenken,
A.V.Eliseenkova,
R.Meech,
C.Tsau,
V.N.Patel,
R.A.Lang,
and
M.Mohammadi
(2009).
Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis.
|
| |
Sci Signal, 2,
ra55.
|
 |
|
|
|
|
 |
J.Kalinina,
S.A.Byron,
H.P.Makarenkova,
S.K.Olsen,
A.V.Eliseenkova,
W.J.Larochelle,
M.Dhanabal,
S.Blais,
D.M.Ornitz,
L.A.Day,
T.A.Neubert,
P.M.Pollock,
and
M.Mohammadi
(2009).
Homodimerization controls the fibroblast growth factor 9 subfamily's receptor binding and heparan sulfate-dependent diffusion in the extracellular matrix.
|
| |
Mol Cell Biol, 29,
4663-4678.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Wang,
X.Cai,
M.Zou,
T.Xu,
S.Liu,
Y.Wang,
J.Wang,
and
D.Xu
(2009).
Construction and characterization of a high activity mutant of human keratinocyte growth factor-2.
|
| |
Biotechnol Lett, 31,
797-802.
|
 |
|
|
|
|
 |
N.Kulahin,
S.Li,
V.Kiselyov,
E.Bock,
and
V.Berezin
(2009).
Identification of neural cell adhesion molecule L1-derived neuritogenic ligands of the fibroblast growth factor receptor.
|
| |
J Neurosci Res, 87,
1806-1812.
|
 |
|
|
|
|
 |
S.Li,
C.Christensen,
L.B.Køhler,
V.V.Kiselyov,
V.Berezin,
and
E.Bock
(2009).
Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons.
|
| |
Dev Neurobiol, 69,
837-854.
|
 |
|
|
|
|
 |
Y.Yaguchi,
T.Yu,
M.U.Ahmed,
M.Berry,
I.Mason,
and
M.A.Basson
(2009).
Fibroblast growth factor (FGF) gene expression in the developing cerebellum suggests multiple roles for FGF signaling during cerebellar morphogenesis and development.
|
| |
Dev Dyn, 238,
2058-2072.
|
 |
|
|
|
|
 |
M.A.Reynolds
(2008).
Molecular alterations in prostate cancer.
|
| |
Cancer Lett, 271,
13-24.
|
 |
|
|
|
|
 |
R.Menezes,
A.Letra,
J.Ruff,
J.M.Granjeiro,
and
A.R.Vieira
(2008).
Studies of genes in the FGF signaling pathway and oral clefts with or without dental anomalies.
|
| |
Am J Med Genet A, 146,
1614-1617.
|
 |
|
|
|
|
 |
S.Oltean,
P.G.Febbo,
and
M.A.Garcia-Blanco
(2008).
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.
|
| |
Clin Exp Metastasis, 25,
611-619.
|
 |
|
|
|
|
 |
V.N.Patel,
K.M.Likar,
S.Zisman-Rozen,
S.N.Cowherd,
K.S.Lassiter,
I.Sher,
E.A.Yates,
J.E.Turnbull,
D.Ron,
and
M.P.Hoffman
(2008).
Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation.
|
| |
J Biol Chem, 283,
9308-9317.
|
 |
|
|
|
|
 |
I.Shams,
E.Rohmann,
V.P.Eswarakumar,
E.D.Lew,
S.Yuzawa,
B.Wollnik,
J.Schlessinger,
and
I.Lax
(2007).
Lacrimo-auriculo-dento-digital syndrome is caused by reduced activity of the fibroblast growth factor 10 (FGF10)-FGF receptor 2 signaling pathway.
|
| |
Mol Cell Biol, 27,
6903-6912.
|
 |
|
|
|
|
 |
J.Kosman,
N.Carmean,
E.M.Leaf,
K.Dyamenahalli,
and
J.A.Bassuk
(2007).
Translocation of fibroblast growth factor-10 and its receptor into nuclei of human urothelial cells.
|
| |
J Cell Biochem, 102,
769-785.
|
 |
|
|
|
|
 |
M.Entesarian,
J.Dahlqvist,
V.Shashi,
C.S.Stanley,
B.Falahat,
W.Reardon,
and
N.Dahl
(2007).
FGF10 missense mutations in aplasia of lacrimal and salivary glands (ALSG).
|
| |
Eur J Hum Genet, 15,
379-382.
|
 |
|
|
|
|
 |
R.Goetz,
A.Beenken,
O.A.Ibrahimi,
J.Kalinina,
S.K.Olsen,
A.V.Eliseenkova,
C.Xu,
T.A.Neubert,
F.Zhang,
R.J.Linhardt,
X.Yu,
K.E.White,
T.Inagaki,
S.A.Kliewer,
M.Yamamoto,
H.Kurosu,
Y.Ogawa,
M.Kuro-o,
B.Lanske,
M.S.Razzaque,
and
M.Mohammadi
(2007).
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
|
| |
Mol Cell Biol, 27,
3417-3428.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Tatekawa,
H.Kanehiro,
and
Y.Nakajima
(2007).
Duodenal atresia associated with "apple peel" small bowel without deletion of fibroblast growth factor-10 or fibroblast growth factor receptor 2IIIb: report of a case.
|
| |
Surg Today, 37,
430-433.
|
 |
|
|
|
|
 |
D.J.Housley,
and
P.J.Venta
(2006).
The long and the short of it: evidence that FGF5 is a major determinant of canine 'hair'-itability.
|
| |
Anim Genet, 37,
309-315.
|
 |
|
|
|
|
 |
E.Cox,
J.Lanier,
L.Quina,
S.R.Eng,
and
E.E.Turner
(2006).
Regulation of FGF10 by POU transcription factor Brn3a in the developing trigeminal ganglion.
|
| |
J Neurobiol, 66,
1075-1083.
|
 |
|
|
|
|
 |
P.Aloy,
and
R.B.Russell
(2006).
Structural systems biology: modelling protein interactions.
|
| |
Nat Rev Mol Cell Biol, 7,
188-197.
|
 |
|
|
|
|
 |
P.Wei,
J.Zhan,
S.Liu,
D.Chang,
R.Haldankar,
K.Burkhardt,
J.Crouse,
J.Hui,
T.Juan,
J.Talvenheimo,
H.Kim,
L.Li,
T.Boone,
and
L.Borges
(2006).
Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptor.
|
| |
Hybridoma (Larchmt), 25,
115-124.
|
 |
|
|
|
|
 |
S.K.Olsen,
J.Y.Li,
C.Bromleigh,
A.V.Eliseenkova,
O.A.Ibrahimi,
Z.Lao,
F.Zhang,
R.J.Linhardt,
A.L.Joyner,
and
M.Mohammadi
(2006).
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
|
| |
Genes Dev, 20,
185-198.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Zhang,
O.A.Ibrahimi,
S.K.Olsen,
H.Umemori,
M.Mohammadi,
and
D.M.Ornitz
(2006).
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
|
| |
J Biol Chem, 281,
15694-15700.
|
 |
|
|
|
|
 |
A.O.Wilkie
(2005).
Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations.
|
| |
Cytokine Growth Factor Rev, 16,
187-203.
|
 |
|
|
|
|
 |
L.Dailey,
D.Ambrosetti,
A.Mansukhani,
and
C.Basilico
(2005).
Mechanisms underlying differential responses to FGF signaling.
|
| |
Cytokine Growth Factor Rev, 16,
233-247.
|
 |
|
|
|
|
 |
M.Entesarian,
H.Matsson,
J.Klar,
B.Bergendal,
L.Olson,
R.Arakaki,
Y.Hayashi,
H.Ohuchi,
B.Falahat,
A.I.Bolstad,
R.Jonsson,
M.Wahren-Herlenius,
and
N.Dahl
(2005).
Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands.
|
| |
Nat Genet, 37,
125-127.
|
 |
|
|
|
|
 |
M.Mohammadi,
S.K.Olsen,
and
O.A.Ibrahimi
(2005).
Structural basis for fibroblast growth factor receptor activation.
|
| |
Cytokine Growth Factor Rev, 16,
107-137.
|
 |
|
|
|
|
 |
M.Mohammadi,
S.K.Olsen,
and
R.Goetz
(2005).
A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs.
|
| |
Curr Opin Struct Biol, 15,
506-516.
|
 |
|
|
|
|
 |
N.Nagy,
G.Szolnoky,
G.Szabad,
Z.Bata-Csörgo,
A.Dobozy,
L.Kemeny,
and
M.Szell
(2005).
Single nucleotide polymorphisms of the fibroblast growth factor receptor 2 gene in patients with chronic venous insufficiency with leg ulcer.
|
| |
J Invest Dermatol, 124,
1085-1088.
|
 |
|
|
|
|
 |
O.A.Ibrahimi,
B.K.Yeh,
A.V.Eliseenkova,
F.Zhang,
S.K.Olsen,
M.Igarashi,
S.A.Aaronson,
R.J.Linhardt,
and
M.Mohammadi
(2005).
Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
|
| |
Mol Cell Biol, 25,
671-684.
|
 |
|
|
|
|
 |
H.Umemori,
M.W.Linhoff,
D.M.Ornitz,
and
J.R.Sanes
(2004).
FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain.
|
| |
Cell, 118,
257-270.
|
 |
|
|
|
|
 |
L.F.Lareau,
R.E.Green,
R.S.Bhatnagar,
and
S.E.Brenner
(2004).
The evolving roles of alternative splicing.
|
| |
Curr Opin Struct Biol, 14,
273-282.
|
 |
|
|
|
|
 |
M.J.Bernett,
T.Somasundaram,
and
M.Blaber
(2004).
An atomic resolution structure for human fibroblast growth factor 1.
|
| |
Proteins, 57,
626-634.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.K.Olsen,
O.A.Ibrahimi,
A.Raucci,
F.Zhang,
A.V.Eliseenkova,
A.Yayon,
C.Basilico,
R.J.Linhardt,
J.Schlessinger,
and
M.Mohammadi
(2004).
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity.
|
| |
Proc Natl Acad Sci U S A, 101,
935-940.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.L.Allen,
and
A.C.Rapraeger
(2003).
Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly.
|
| |
J Cell Biol, 163,
637-648.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|